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Abstract 
 
Aims 
To determine patient and health service factors associated with variation in hospital mortality 
among resuscitated cases of out-of-hospital cardiac arrest (OHCA) with acute coronary syndrome 
(ACS).  
 
Methods 
In this cohort study, we used the Myocardial Ischaemia National Audit Project database to study 
outcomes in patients hospitalised with resuscitated OHCA due to ACS between 2003 and 2015 in 
the United Kingdom. We analysed variation in inter-hospital mortality and used hierarchical 
multivariable regression models to examine the association between patient and health service 
factors with hospital mortality. 
 
Results 
We included 17604 patients across 239 hospitals. Overall hospital mortality was 28.7%. In 94 
hospitals that contributed at least 60 cases, mortality by hospital ranged from 10.7% to 66.3% 
(median 28.6%, IQR 23.2% to 39.1%)). Patient and health service factors explained 36.1% of this 
variation.  
After adjustment for covariates, factors associated with higher hospital mortality included 
increasing serum glucose, ST-Elevation myocardial infarction (STEMI) diagnosis, and initial 
admission to a primary percutaneous coronary intervention (pPCI) capable hospital. Hospital 
OHCA volume was not associated with mortality. The key modifiable factor associated with lower 
mortality was early reperfusion therapy in STEMI patients.  
 
Conclusion 
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There was wide variation in inter-hospital mortality following resuscitated OHCA due to ACS that 
was only partially explained by patient and health service factors. Hospital OHCA volume and 
pPCI capability were not associated with lower mortality. Early reperfusion therapy was associated 
with lower mortality in STEMI patients.  
 
Keywords: Out-of-Hospital Cardiac Arrest; Acute Coronary Syndrome; Myocardial Infarction. 
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Introduction 
Across Europe, the annual incidence of treated out-of-hospital cardiac arrest (OHCA) is 49 cases 
per 100,000 population.[1] Acute coronary syndrome (ACS) is a common cause of OHCA; where 
OHCA cause is recorded, approximately 76% of cases are attributed to cardiac aetiology.[2] 
Variation in OHCA mortality has been described between countries, Emergency Medical Service 
(EMS) systems and admitting hospitals.[1-3]  
 
Regional cardiac arrest centres have been proposed as a strategy to reduce inter-hospital variation in 
OHCA mortality, but the quality of evidence supporting the concept is low.[4, 5] Regionalised care 
systems are based on the premise that the benefit of immediate admission to a hospital with 
specialist facilities and expertise outweighs any risk associated with a potentially increased 
transport time. Such systems are already established in major trauma and stroke.[6, 7]  
 
In OHCA, improved understanding of inter-hospital variation in mortality is essential to improve 
understanding of the potential value of regionalised care systems. The availability in England and 
Wales of the only nation-wide ACS registry (Myocardial Ischaemia National Audit Project, 
MINAP) provides a unique opportunity to better understand these factors. Our study objective was 
to identify if there was evidence of inter-hospital variation in mortality among resuscitated cases of 
OHCA caused by ACS in the UK, and to identify the patient and health service factors that might 
contribute to any variation.   
 
 
Methods 
Data source 
MINAP is a national registry of patients admitted to hospital with acute coronary syndromes. 
Established in 1998, it provides a mechanism for participating hospitals to benchmark performance 
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against national standards.[8] MINAP participation is mandatory, with all acute hospitals in 
England and Wales participating since 2003. Detailed care quality and clinical outcome data are 
collected at the hospital level, with entry validated through real-time checks and an annual hospital 
data validation review. This study linked MINAP to UK Office of National Statistics (ONS) data to 
provide information on patient social deprivation and enrich mortality data. MINAP identifies 
patients using their unique NHS number, which is pseudo-anonymised in the database. Patient 
identifiers (for example, date of birth) are encrypted prior to transfer to the central database, and are 
not released to researchers.  
 
Patient eligibility 
In this study, we included adult patients in the MINAP dataset where the initial cardiac arrest event 
occurred in the pre-hospital setting and where initial resuscitation attempts were successful leading 
to hospital admission. We excluded non-index (second or subsequent) cardiac arrests, events where 
the initial cardiac arrest event occurred in the in-hospital setting, and patients where the primary 
outcome was unknown.  
 
Data definitions 
For hospital-level data (volume, primary percutaneous coronary intervention (pPCI) capability, EMS 
distance), patients were categorised by the hospital to which they were first admitted. For hospital 
volume, the number of OHCA cases in each year at each hospital was calculated. Each patient was 
allocated to a volume category (low: 1-10 cases; medium: 11-24 cases; high: ≥25 cases) based on the 
hospital and year in which they were treated. We categorised patients as being treated in a pPCI 
capable hospital if it performed at least 100 pPCI procedures across all patients in the MINAP dataset 
in the year that the patient was admitted, as per UK guidance.[9] EMS distance was calculated as the 
Euclidian distance between the patient’s home address and hospital. This assumed the OHCA event 
occurred at the patient’s home, which is true for over 80% of UK OHCAs.[2]  
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Reperfusion treatment was categorised as early or late. Thrombolysis was classified as early if call-
to-needle time was up to 60 minutes, based on UK national standards.[10] PPCI was classified as 
early if door-to-balloon time was up to 90 minutes, based on the MINAP benchmark.[11] 
 
For sub-group analyses, we categorised patients, based on the MINAP variable ‘ECG determining 
treatment,’ as having STEMI (ST-elevation acute myocardial infarction or presumed new left 
bundle branch block (LBBB)) or NSTEACS (non-ST Elevation Acute Coronary Syndrome,  which 
included all patients that did not meet the STEMI definition including unstable angina patients).  
 
Outcome measures 
The primary outcome was all-cause hospital mortality, as recorded in the MINAP dataset or, where 
this was incomplete, cross-referencing with ONS mortality data.  
 
Sample size 
Preliminary data supplied by MINAP led to a projected sample size of 14,310 eligible OHCA cases 
with a projected hospital mortality of 24%. Based on this, we calculated a 4% difference in 
mortality between categories within a predictor variable could be detected reliably with at least 90% 
power and a significance level of 0.05.  
 
Statistical analysis 
Multiple imputation using chained equations was used to reduce the bias associated with missing 
data in predictor variables (Supplementary Data Table S1), based on the approach used in previous 
MINAP analyses.[12, 13] Case identification and sub-group allocation was undertaken prior to 
imputation. Twenty-five imputed datasets were generated.  
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After imputation, an unadjusted random effects logistic regression model was fitted to predict 
hospital mortality and obtain the estimate for the log of the odds ratio and the standard error for 
each imputed dataset. The inclusion of a random effects term for the hospital enabled variation 
between hospitals to be modelled. Estimates from each of the 25 imputed datasets were combined 
using the Rubin’s rules to get an overall odds ratio estimate of mortality, 95% confidence interval 
and p-value.[14] We adopted a similar approach for the adjusted analysis. The model included all 
clinically relevant predictor variables, unless there was evidence of multi-collinearity due to two 
predictors being highly correlated or a variable was clearly confounded by an unmeasured variable.  
 
Alongside data from the whole cohort, we report data from STEMI and NSTEACS sub-groups, and 
sensitivity analyses (complete case; admission between 2003 and 2008; admission between 2009 
and 2015). This sensitivity analysis cut-off reflects the year (2009) that pPCI became the most 
commonly recorded reperfusion treatment in MINAP.[11]   
 
Data processing and descriptive analyses pre-imputation were performed using SPSS version 22 
(IBM Corp, Armonk, NY, USA). The R statistical program (R: A language and environment for 
statistical computing, R development core team; R Foundation for Statistical Computing, Vienna, 
Austria) and associated packages (MICE and gamm4 packages) were used for multiple imputation, 
descriptive analysis after multiple imputation, and fitting models for hospital mortality.  
  
Ethics/ approvals 
The study was undertaken in accordance with the Declaration of Helsinki. The University of 
Warwick Biomedical Research Ethics Committee approved the study. MINAP, as part of the 
National Institute for Cardiovascular Outcomes Research, is approved under UK legislation to hold 
patient identifiable data without consent.  
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Results 
Study population 
There were 1127140 patient datasets collected by MINAP between January 2003 and June 2015 
(Figure 1). Of these, 73875 (6.6%) were identified as having had a cardiac arrest. Sequential 
application of study exclusion criteria led to the exclusion of 56271 patients, most of whom had 
sustained an in-hospital cardiac arrest (N=50836, 90.3%). The study sample included data from 
17604 patients across 239 hospitals. The median number of cases reported per hospital over the 
study period was 46 (range 1-517). Neurological outcome data were available for 15286 patients.  
 
The number of cases included annually increased over the study period, with a peak of 2129 cases 
in 2012 (Supplementary Data Figure S1).  
 
 
Patient characteristics (whole cohort) 
Patients were predominantly male (n=13188, 75.1%) with a mean age of 65.3 years (Table 1). The 
most common co-morbidity was hypertension (n=6389, 41.0%). OHCA events typically occurred 
prior to EMS arrival (n=10533, 60.1%) with a shockable presenting rhythm (n=14778, 89.6%). 
Most were classified as STEMI (n=12220, 71.9%), and were admitted to the coronary care 
(N=8872, 51.0%) or intensive care (N=6154, 35.4%) unit. Most patients received reperfusion 
therapy (n=9540, 62.9%), of which the majority received pPCI (n=6160, 64.6%). Reperfusion 
therapy use increased over time (2003: 20.8%; 2015: 64.1%), with increases in pPCI use mirrored 
by a decline in thrombolysis use across all patients, and in STEMI/ NSTEACS sub-groups (Figure 
2). Over the study period, the percentage of patients admitted to pPCI capable hospitals increased 
(2003: 0%; 2014: 81%) and the percentage admitted to low-volume OHCA hospitals decreased 
(Figure 3; Supplementary Data Figure S2).  
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Length of stay and patient outcomes 
Overall hospital mortality was 28.7% (n=5047) and 40.9% (n=6245) died or were discharged with 
neurological deficit. In non-survivors, median time to death was 2 days (IQR 1-5, range 0-96) 
(Supplementary Data Figure S3). For survivors, median length of hospital stay was 7 days (IQR 3-
14, range 0-372) (Supplementary Data Figure S4).  
 
 
Variation in inter-hospital mortality 
In the 94 hospitals that contributed at least 60 cases over the study period, hospital mortality by 
hospital ranged from 10.7% to 66.3% (median 28.6%, IQR 23.2% to 39.1%) (Supplementary Data 
Figure S5).  
 
Demographic and medical history variables explained little variation, with age (R2=0.060) having the 
highest R2 value (Supplementary Data Table S2). A greater degree of variation was explained by 
some OHCA presenting characteristic and care pathway variables, such as OHCA rhythm 
(R2=0.104), serum glucose (R2 =0.083), and admission ward (R2=0.178). Little variation was 
explained by OHCA hospital volume (R2=0.006), hospital pPCI capability (R2=0.003) and 
reperfusion therapy (R2=0.042). The adjusted analysis explained 36.1% (R2=0.361) of the variation 
across the dataset (Table 2). 
 
Factors influencing mortality 
Across the whole cohort, after co-variate adjustment, demographic factors associated with increased 
mortality included increasing age and social deprivation (Table 2). Other factors associated with 
higher mortality included female gender, history of heart failure, increasing blood glucose, OHCA 
prior to EMS arrival, and STEMI or LBBB on the initial ECG. Hypertension, 
hypercholesterolaemia, and a shockable OHCA rhythm were associated with lower mortality.  
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Health service factors that did not influence mortality include time of day of admission, hospital 
OHCA volume, EMS response time, and first ECG location. Admission to a pPCI capable hospital 
was associated with higher mortality (OR 1.26, 95% CI 1.05-1.53). A supplementary analysis 
identified case-mix differences between patients treated in pPCI capable and non-pPCI capable 
hospitals. More patients initially admitted to a pPCI capable hospital presented in a shockable 
OHCA rhythm (92.8% v 86.9%), had a STEMI diagnosis, (84.4% v 61.5%), and were in 
cardiogenic shock (21.9% v 5.7%) (Supplementary Data Table S3).  
 
Hospital admission under a cardiologist (OR 0.73, 95% CI 0.64-0.82) was associated with lower 
mortality. Early reperfusion treatment was the key modifiable health service factor associated with 
reduced mortality (early thrombolysis 0.67, 95% CI 0.52-0.86; early pPCI OR 0.70, 95% CI 0.60-
0.83).  
 
 
STEMI and NSTEACS cohorts 
Adjusted models restricted to STEMI and NSTEACS cohorts explained a similar degree of 
variation as the primary analysis (STEMI: R2=0.354; NSTEMI R2= 0.365) (Table 2). Compared to 
STEMI patients, NSTEACS patients were older (mean age 68.3 v 63.9 years), had more co-
morbidities, and were more likely to present in a non-shockable OHCA rhythm (Table 1). 
NSTEACS patients were less likely to be admitted to a high-volume OHCA (11.2% v 20.6%) or 
pPCI capable (25.3% v 53.3%) hospital, and less likely to receive reperfusion therapy (9.9% v 
81.7%).  
 
Admission to pPCI hospital was associated with higher mortality in STEMI (OR 1.58, 95% CI 
1.26-1.99) but not in NSTEACS (OR 0.85, 95% CI 0.61-1.19) patients. Reperfusion therapy was 
associated with lower mortality in STEMI patients, but not in NSTEACS patients (e.g. early pPCI 
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STEMI OR 0.62, 95% CI 0.52-0.74; NSTEACS OR 0.80, 95% CI 0.43-1.50). Compared to 
daytime, overnight admission was associated with higher mortality in the NSTEACS (OR 1.20, 
95% CI 1.01-1.43), but not the STEMI (OR 1.04, 95% CI 0.93-1.16) group. 
 
Sensitivity analyses 
Sensitivity analyses for the complete case (n=2284, 13.0%), 2003-2008 (n=6075, 34.5%), and 
2009-2015 (n=11529, 65.5%) cohorts, explained a similar degree of variation to the primary 
analysis (Supplementary Data Table S4). Findings of these analyses were generally consistent with 
the primary analysis, albeit confidence intervals were typically wider. Point estimates for most 
reperfusion treatments in the complete case cohort indicated higher mortality, which may reflect a 
selection bias inasmuch as a complete dataset is likely easier to collect in patients that die.  
 
Discussion 
In this analysis of 17604 OHCA patients with ACS, admitted alive to 239 UK hospitals, just under 
three in ten died in hospital. Across the 94 hospitals contributing at least 60 cases, we identified 
wide variation in inter-hospital mortality. Modelling explained approximately one third of this 
variation. Over the 12-year study period, we observed changes in clinical practice, including 
increased admission of patients to pPCI capable hospitals and high-volume OHCA hospitals, and 
increased use of reperfusion treatment. The key modifiable factor associated with lower hospital 
mortality in STEMI patients was early reperfusion treatment.  
 
Previous studies of OHCA have been inconsistent as to the association between hospital facilities, 
OHCA volume and outcome, which may be partly reflect variability in how these concepts are 
defined across the literature.[15-18] In contrast to the findings of a recent analysis of the American 
Cardiac Arrest Registry to Enhance Survival dataset, we unexpectedly observed an association 
between admission to a pPCI capable hospital and higher mortality.[19]  This finding may be partly 
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explained by case-mix differences between patients treated in pPCI and non-pPCI capable hospitals. 
In particular, a higher proportion of patients in cardiogenic shock were admitted to pPCI capable 
hospitals, although the degree of missingness within this variable precluded its imputation and 
modelling.  
 
The decisions by paramedics as to the most appropriate hospital to which to transfer a patient for 
ongoing treatment may be influenced by patient condition, hospital facilities, patient preference, 
local care pathways, and transfer time. Increased transfer time may increase the risk of clinical 
adverse events, but, in keeping with previous studies, we observed no harm associated with 
increasing transport distance.[15, 20]  
 
In line with previous ACS studies, we observed an association between increasing admission blood 
glucose and higher mortality.[21, 22] Active management of hyperglycaemia in ACS has been 
associated with improved outcome,[23] and is recommended in international guidelines.[24, 25] 
Our study did not analyse the medical management of hyperglycaemia, but our findings highlight a 
need for further research on this potentially modifiable clinical parameter. 
 
Our findings indicate the widespread implementation of evidence-based guidelines for the 
immediate management of myocardial infarction following OHCA.[24, 25] Most STEMI patients 
(81.7%) and some NSTEACS patients (9.9%) received reperfusion therapy. In keeping with clinical 
trial data, early reperfusion treatment was associated with lower mortality in STEMI patients.[26, 
27] 
 
We used the MINAP dataset to analyse outcomes in OHCA due to ACS. The key advantages to this 
dataset are national coverage and longevity. For the purpose of this study, its key limitation was that 
it does not capture key variables relevant to OHCA such as location (public v private) and bystander 
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CPR. Future studies may consider enriching MINAP data through linkage with other relevant UK 
datasets, such as the OHCA outcomes project and intensive care case mix programme.[2, 28] The 
OHCA outcomes project could provide key data on OHCA characteristics, but was established only 
in 2013 thereby limiting the opportunity for linkage. The intensive care case mix programme was 
established in the 1990s, but only approximately one in three patients in this study was admitted to 
the intensive care unit and the case mix programme does not directly collect provision of targeted 
temperature management although this may be derived from other variables.[29] 
 
Our study has the limitations inherent in all observational studies. In particular, despite its large size 
and use of complex statistical analyses, our findings may be affected by unmeasured residual 
confounders. A key challenge in analysing audit datasets such as MINAP is the management of 
missing data.[13] Whilst we used sophisticated techniques to impute data, the degree of missingness 
in some important variables, such as Killip class, precluded this approach. Finally, there is known 
inter-hospital variation in methods used to identify patients for reporting to MINAP, particularly in 
NSTEACS patients, which may lead to selection bias.[11] 
 
 
Conclusions 
This large cohort study of patients with OHCA due to ACS found evidence of marked variation in 
mortality between hospitals, which was not fully explained by modelled patient and health service 
factors. Whilst we observed no association between cardiac arrest centre characteristics (volume, 
pPCI capability) and lower mortality, the early use of reperfusion treatment, which is likely to be 
available only in such centres, was associated with lower mortality in STEMI patients. 
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Figure legends 
Figure legends 
Figure 1: Flow chart of case identification process 
Figure 2: Reperfusion rates by year across the whole cohort, STEMI cases, and NSTEACS cases. 
Figure 3: Percentage of patients admitted to pPCI capable centres by year 
 
Text tables 
Table 1: Patient characteristics across all cases, STEMI cases and NSTEACS cases 
Table 2: Multiviariate analysis across all cases, STEMI cases and NSTEACS cases 
 
A supplementary data file has been supplied.  
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Figure three 
 
 
 
Table 1: Patient characteristics across all cases, STEMI cases and NSTEACS cases 
 All cases (n= 17604)† STEMI (n=12,220)† NSTEACS (n=4,772)† 
Demographic variables    
Age (Years)- Mean (SD) 65.3 (13.15) 63.9 (13.06) 68.3 (12.73) 
Gender (Female)- n (%) 4,370 (24.9) 3,034 (24.9) 1,155 (24.2) 
Ethnicity, n (%) 
      White 
      Asian 
      Black 
      Other 
 
14,343 (93.7) 
531 (3.5) 
131 (0.9) 
303 (2.0) 
 
9,927 (93.4) 
386 (3.6) 
88 (0.8) 
230 (2.2) 
 
3,904 (94.3) 
135 (3.3) 
40 (1.0) 
63 (1.5) 
Index of multiple deprivation score- Mean (SD) 22.31 (15.91) 22.27 (15.92) 22.42 (15.94) 
 
Medical history variables- n (%) 
   
Smoking status- Ever smoked 8,883 (63.5) 6,510 (65.8) 2,157 (57.9) 
Diabetes status- Diabetic 2,158 (13.7) 1,283 (11.8) 795 (18.2) 
Hypercholesterolaemia- Yes 3,906 (25.9) 2,600 (24.9) 1,197 (28.4) 
Heart failure- Yes 760 (5.0) 356 (3.4) 359 (8.4) 
Cerebrovascular disease- Yes 1,071 (7.0) 609 (5.7) 419 (9.8) 
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 All cases (n= 17604)† STEMI (n=12,220)† NSTEACS (n=4,772)† 
Previous MI- Yes 3,092 (19.7) 1,701 (15.7) 1,243 (28.5) 
Asthma or COPD- Yes 1,814 (11.9) 1,161 (11.0) 569 (13.3) 
Chronic renal failure- Yes 555 (3.6) 272 (2.6) 252 (5.9) 
Peripheral vascular disease- Yes 587 (3.9) 358 (3.4) 208 (4.9) 
Previous Angina- Yes 2,758 (17.8) 1,501 (14.0) 1,133 (26.3) 
Previous PCI- Yes 1,061 (6.9) 670 (6.3) 357 (8.3) 
Previous CABG- Yes 790 (5.1) 374 (3.5) 395 (9.1) 
Hypertension- Yes 6,389 (41.0) 4,186 (38.8) 2,007 (46.3) 
 
OHCA presenting characteristics 
   
Time point of cardiac arrest, n (%) 
      Before ambulance arrival 
      After ambulance arrival 
 
10,533 (60.1) 
7,004 (39.9) 
 
6,371 (52.3) 
5,811 (47.7) 
 
3,747 (78.7) 
1,013 (21.3) 
Cardiac arrest rhythm, n (%) 
     Asystole 
      PEA 
      VF/ VT 
 
885 (5.4) 
837 (5.1) 
14,778 (89.6) 
 
422 (3.7) 
444 (3.8) 
10,691 (92.5) 
 
388 (8.8) 
353 (8.0) 
3,665 (83.2) 
Serum glucose (mmol/L)- Mean (SD) 10.94 (5.00) 10.92 (4.91) 10.99 (5.23) 
Creatinine (micromol/ L)- Mean (SD) 108.12 (55.72) 104.12 (49.86) 117.80 (67.17) 
Left Ventricular Ejection Fraction, n (%) 
      Good 
      Moderate 
      Poor 
 
2,783 (36.4) 
3,131 (40.9) 
1,736 (22.7) 
 
1,873 (34.3) 
2,347 (43.0) 
1,233 (22.6) 
 
858 (41.4) 
744 (35.9) 
469 (22.6) 
Haemoglobin (g/dL)- Mean (SD) 13.57 (2.03) 13.69 (2.01) 13.27 (2.05) 
Serum cholesterol (mmol/L)- Mean (SD) 4.80 (1.51) 4.91 (1.47) 4.46 (1.64) 
Admission diagnosis, n (%) 
      Definite MI – anterior infarction 
      Definite MI – other infarction site 
      Other initial diagnosis 
 
3,897 (27.0) 
3,639 (25.2) 
6,883 (47.7) 
 
3,809 (40.6) 
3,463 (36.9) 
2,105 (22.4) 
 
78 (1.7) 
159 (3.5) 
4,306 (94.8) 
Admission systolic BP (mmHg)- Mean (SD) 125.69 (29.17) 124.95 (28.75) 127.27 (29.86) 
ECG that determined treatment, n (%) 
      ST elevation or LBBB 
      ST depression/ T wave changes only 
      Other change/ No acute changes 
 
12,220 (71.9) 
2,325 (13.7) 
2,447 (14.4) 
 
12,220 (100.0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
2,325 (48.7%) 
2,447 (51.3%) 
Admission heart rate (/minute)- Mean (SD) 89.22 (24.79) 88.55 (24.10) 90.54 (26.12) 
Daytime hospital admission (8am to < 8pm)- n (%) 11,741 (66.7%) 8,083 (66.1%) 3,272 (68.6%) 
Killip Class, n (%) 
      Basal crepitations and/or elevated venous pressure 
      Pulmonary oedema 
      Cardiogenic shock 
      No evidence of heart failure 
 
796 (13.8) 
317 (5.5) 
1,029 (17.9) 
3,612 (62.8) 
 
517 (12.1) 
228 (5.3) 
853 (20.0) 
2,665 (62.5) 
 
269 (18.5) 
89 (6.1) 
169 (11.6) 
927 (63.8) 
Mini-Grace score-  Mean (SD) 173 (28.37) 174 (27.92) 172 (29.38) 
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 All cases (n= 17604)† STEMI (n=12,220)† NSTEACS (n=4,772)† 
Care pathway variables 
Hospital volume (OHCA cases per year)- n (%) 
      1 to 10 cases 
      11 to 24 cases 
      25 to 82 cases 
 
7,984 (45.4) 
6,516 (37.0) 
3,104 (17.6) 
 
4,900 (40.1) 
4,799 (39.3) 
2,521 (20.6) 
 
2,673 (56.0) 
1,565 (32.8) 
534 (11.2) 
Hospital pPCI capability- n (%) 
      pPCI capable 
      pPCI incapable  
 
7,800 (44.3) 
9,804 (55.7) 
 
6,514 (53.3) 
5,706 (46.7) 
 
1,205 (25.3) 
3,567 (74.7) 
EMS response time (Minutes)- Mean (SD) 11.53 (11.82) 12.03 (12.42) 10.29 (10.11) 
EMS travel distance (Kilometres)- Mean (SD) 11.24 (10.08) 11.96 (10.50) 9.67 (8.88) 
Admitting consultant, n (%)-  
      Cardiologist 
      Other consultant 
 
10,680 (61.8) 
6,603 (37.5) 
 
8,480 (70.6) 
3,534 (29.4) 
 
2,008 (42.8) 
2,689 (57.2) 
Cardiological care during admission- yes- n (%) 11,960 (90.7) 8,797 (93.3) 2,975 (85.0) 
Admission Ward, n (%) 
      CCU 
      Cardiac ward - non CCU 
      Intensive therapy unit 
      General medical ward or Other 
      Died in Emergency Department 
 
8,872 (51.0) 
500 (2.9) 
6,154 (35.4) 
1,534 (8.8) 
340 (1.9) 
 
6,984 (57.9) 
366 (3.0) 
3,666 (30.4) 
868 (7.2) 
176 (1.5) 
 
1,683 (35.4) 
123 (2.6) 
2,290 (48.2) 
558 (11.8) 
94 (2.0) 
Place where ECG performed, n (%) 
      Pre-hospital 
      In hospital 
 
11,053 (75.7) 
3,551 (24.3) 
 
8,253 (79.2) 
2,162 (20.8) 
 
2,659 (67.0) 
1,311 (33.7) 
Reperfusion treatment and timing, n (%) 
      None 
      Thrombolysis (early) 
      Thrombolysis (late) 
      Thrombolysis (time missing) 
      pPCI (early) 
      pPCI (late) 
      pPCI (time missing) 
 
5,633 (37.1) 
1,080 (7.1) 
1,930 (12.7) 
370 (2.4) 
4,424 (29.2) 
1,063 (7.0) 
673 (4.4) 
 
2,048 (18.3) 
1,053 (9.4) 
1,832 (16.4) 
314 (2.8) 
4,293 (38.5) 
994 (8.9) 
631 (5.7) 
 
2,350 (90.1) 
20 (0.5) 
85 (2.3) 
40 (1.1) 
122 (3.3) 
65 (1.7) 
36 (1.0) 
 
Discharge care variables 
   
Discharge Diagnosis, n (%) 
      Acute coronary syndrome 
      Other diagnosis 
 
16,476 (95.1) 
843 (4.9) 
 
11,710 (97.5) 
304 (2.5) 
 
4,232 (89.8) 
483 (10.2) 
Echocardiography- yes/ planned- n (%) 11,140 (73.8) 7,902 (75.2) 
 
2,990 (72.6) 
Outcomes 
Survival to hospital discharge-n (%) 
 
12,557 (71.3) 
 
9,049 (74.1) 
 
3,184 (66.7) 
Discharged without neurological deficit- n (%)‡ 9,041 (59.1) 6,736 (62.9) 2,081 (51.4) 
    
Page 25 
 
 All cases (n= 17604)† STEMI (n=12,220)† NSTEACS (n=4,772)† 
†- The n for each variable is the total group size minus the number of missing cases (see supplementary information). 612 cases were missing STEMI status, 
so not included in the sub-groups.  
CABG- Coronary Artery Bypass Graft; CCU- Cardiac Care Unit; COPD- Chronic Obstructive Pulmonary Disease; ECG- Electrocardiogram;  EMS- 
Emergency Medical Service; LBBB- Left Bundle Branch Block; MI- Myocardial Infraction; OHCA- Out-of-Hospital Cardiac Arrest; (p)PCI- (primary) 
Percutaneous Coronary Intervention; PEA- Pulseless Electrical Activity; VF- Ventricular Fibrillation; VT- Ventricular Tachycardia 
 
 
 
 
Table 2: Multivariable analysis across all cases, STEMI cases and NSTEACS cases 
  Odds ratio of in-hospital mortality (95% confidence intervals), p-value* 
  All cases (n=17,604) STEMI (n=12,220) NSTEACS (n=4,772) 
 
Demographic variables 
   
Age (Years)** 1.046 (1.042, 1.051), <0.001 1.048 (1.043, 1.054), <0.001 1.048 (1.040, 1.056), <0.001 
Gender Male 
Female† 
0.877 (0.786, 0.979), 0.019 0.921 (0.806, 1.052), 0.226 0.758 (0.621, 0.925), 0.006 
Ethnicity Asian 
Black 
Other 
White† 
1.022 (0.804, 1.299), 0.860 
0.939 (0.602, 1.464), 0.780 
0.991 (0.723, 1.358), 0.956 
0.961 (0.725, 1.275), 0.783 
0.833 (0.509, 1.364), 0.468 
1.023 (0.726, 1.440), 0.898 
1.167 (0.702, 1.939), 0.551 
1.059 (0.511, 2.198), 0.877 
0.871 (0.417, 1.819), 0.713 
Index of multiple deprivation score** 1.005 (1.002, 1.008), 0.003 1.002 (0.998, 1.006), 0.323 1.010 (1.004, 1.016), 0.002 
 
Medical history variables† 
   
Smoking status- ever smoked 0.903 (0.812, 1.004), 0.059 0.875 (0.765, 1.000), 0.050 1.009 (0.830, 1.226), 0.927 
Diabetes status- Diabetic 1.125 (0.981, 1.290), 0.092 1.162 (0.976, 1.384), 0.091 1.123 (0.890, 1.416), 0.329 
Hypercholesterolaemia 0.692 (0.615, 0.779), <0.001 0.669 (0.577, 0.776), <0.001 0.684 (0.551, 0.850), 0.001 
Heart failure 1.318 (1.074, 1.618), 0.008 1.584 (1.178, 2.128), 0.002 1.192 (0.874, 1.624), 0.267 
Cerebrovascular disease 1.299 (1.097, 1.537), 0.002 1.075 (0.858, 1.348), 0.529 1.703 (1.294, 2.241), <0.001 
Previous MI 1.028 (0.900, 1.173), 0.685 0.997 (0.836, 1.188), 0.971 1.118 (0.899, 1.39), 0.327 
Asthma or COPD 1.247 (1.087, 1.431), 0.002 1.228 (1.030, 1.463), 0.022 1.246 (0.975, 1.591), 0.079 
Chronic renal failure 1.065 (0.841, 1.350), 0.601 0.864 (0.613, 1.219), 0.406 1.390 (0.969, 1.995), 0.073 
Peripheral vascular disease 1.517 (1.208, 1.904), <0.001 1.723 (1.286, 2.309), <0.001 1.338 (0.903, 1.981), 0.146 
Previous angina 1.011 (0.885, 1.156), 0.867 1.037 (0.869, 1.239), 0.684 0.926 (0.743, 1.154), 0.494 
Previous PCI 1.025 (0.840, 1.251), 0.806 1.051 (0.815, 1.356), 0.700 0.923 (0.652, 1.305), 0.649 
Previous CABG 0.996 (0.811, 1.222), 0.966 1.189 (0.894, 1.583), 0.235 0.830 (0.607, 1.135), 0.244 
Hypertension 0.865 (0.784, 0.955), 0.004 0.849 (0.752, 0.960), 0.009 0.866 (0.723, 1.038), 0.120 
 
OHCA presenting characteristics 
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  Odds ratio of in-hospital mortality (95% confidence intervals), p-value* 
  All cases (n=17,604) STEMI (n=12,220) NSTEACS (n=4,772) 
Time point of 
cardiac arrest 
After EMS arrive 
Before EMS arrival† 
0.492 (0.441, 0.548), <0.001 0.483 (0.425, 0.548), <0.001 0.424 (0.331, 0.544), <0.001 
Cardiac arrest 
rhythm 
PEA 
VF/ VT 
Asystole† 
0.847 (0.658, 1.088), 0.194 
0.217 (0.180, 0.262), <0.001 
0.730 (0.507, 1.051), 0.091 
0.189 (0.145, 0.247), <0.001 
0.846 (0.573, 1.248), 0.399 
0.231 (0.172, 0.310), <0.001 
Serum glucose** 1.109 (1.096, 1.122), <0.001 1.113 (1.097, 1.130), <0.001 1.103 (1.081, 1.126), <0.001 
Haemoglobin** 0.912 (0.878, 0.946), <0.001 0.920 (0.884, 0.958), <0.001 0.892 (0.842, 0.945), <0.001 
Serum cholesterol** 0.956 (0.906, 1.010), 0.108 0.953 (0.892, 1.017), 0.150 0.980 (0.910, 1.056), 0.595 
Admission diagnosis Other diagnosis 
Definite MI – other infarct site 
Definite MI – anterior infarct† 
0.876 (0.750, 1.024), 0.097 
1.022 (0.890, 1.173), 0.762 
 
1.005 (0.850, 1.188), 0.956 
1.029 (0.898, 1.179), 0.679 
 
0.586 (0.329, 1.043), 0.069 
1.192 (0.603, 2.358), 0.614 
Admission systolic 
blood pressure 
Linear term*** 
Quadratic term*** 
-42.15 (-48.35, -35.96), <0.001 
17.68 (11.79, 23.57), <0.001 
-33.76 (-40.3, -27.3), <0.001 
16.96 (11.00, 22.92), <0.001 
-23.45 (-29.6, -17.3), <0.001 
6.42 (0.46, 12.38), 0.035 
ECG that determined 
treatment 
ST elevation or LBBB 
ST depression/ T wave changes only 
Other change/ No acute changes† 
1.592 (1.364, 1.858), <0.001 
0.907 (0.775, 1.062), 0.227 
Only ST elevation/ LBBB patients 
included in this analysis 
Data not included 
0.859 (0.728, 1.014), 0.073 
Admission heart rate** 1.005 (1.004, 1.007), <0.001 1.006 (1.004, 1.008), <0.001 1.005 (1.002, 1.008), 0.004 
Time of the day of 
admission  
8pm to <8am (night) 
8am to <8pm (day)† 
1.091 (0.994, 1.196), 0.066 1.037 (0.926, 1.163), 0.528 1.203 (1.010, 1.433), 0.038 
Admission year** Slope (2003 to 2008) 
Slope (2009 to 2015) 
0.947 (0.895, 1.002), 0.057 
1.044 (1.009, 1.079), 0.012 
0.996 (0.931, 1.066), 0.916 
1.038 (0.998, 1.081), 0.065 
0.885 (0.810, 0.968), 0.008 
1.016 (0.953, 1.082), 0.632 
 
Care pathway variables 
   
Hospital volume 
(OHCA cases per 
year) 
0 – 10 cases 
11 - 24 cases 
25 to 82 cases† 
1.033 (0.723, 1.474), 0.860 
1.259 (0.877, 1.808), 0.211 
1.229 (0.904, 1.670), 0.189 
1.242 (0.926, 1.667), 0.148 
0.688 (0.386, 1.229), 0.207 
0.948 (0.534, 1.681), 0.854 
Hospital pPCI 
capability 
pPCI capable 
pPCI incapable† 
1.262 (1.043, 1.527), 0.017 1.584 (1.261, 1.989), <0.001 0.849 (0.605, 1.190), 0.342 
EMS response time (Mins)** 0.999 (0.995, 1.004), 0.776 1.000 (0.995, 1.005), 0.996 0.997 (0.987, 1.007), 0.589 
EMS travel distance (Km)** 0.994 (0.989, 0.999), 0.024 0.992 (0.986, 0.998), 0.012 0.997 (0.987, 1.008), 0.612 
Admitting consultant Cardiologist 
Other consultant† 
0.725 (0.641, 0.822), <0.001 0.794 (0.680, 0.927), 0.003 0.615 (0.494, 0.766), <0.001 
Admission ward Intensive therapy unit 
Died in ED  
General ward or other 
Cardiac ward – non CCU 
CCU† 
3.741 (3.331, 4.202), <0.001 
Not estimable  
3.452 (2.941, 4.051), <0.001 
1.212 (0.841, 1.748), 0.302 
3.267 (2.852, 3.742), <0.001 
Not estimable  
3.549 (2.884, 4.368), <0.001 
1.148 (0.728, 1.810), 0.552 
5.239 (4.107, 6.685), <0.001 
Not estimable  
3.575 (2.642, 4.838), <0.001 
1.588 (0.861, 2.929), 0.138 
Place where ECG 
performed 
In hospital 
Pre hospital† 
1.125 (0.970, 1.304), 0.120 1.127 (0.956, 1.329), 0.154 1.088 (0.878, 1.348), 0.439 
Reperfusion 
treatment and timing 
 
Thrombolysis (early) 
Thrombolysis (late) 
Thrombolysis (time missing) 
pPCI (early) 
0.672 (0.523, 0.863), 0.002 
0.860 (0.723, 1.023), 0.088 
0.954 (0.702, 1.298), 0.766 
0.704 (0.600, 0.826), <0.001 
0.714 (0.550, 0.926), 0.011 
0.893 (0.741, 1.075), 0.231 
0.940 (0.672, 1.315), 0.717 
0.618 (0.518, 0.737), <0.001 
0.501 (0.121, 2.071), 0.340 
0.939 (0.480, 1.837), 0.854 
1.248 (0.500, 3.117), 0.635 
0.802 (0.430, 1.498), 0.490 
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  Odds ratio of in-hospital mortality (95% confidence intervals), p-value* 
  All cases (n=17,604) STEMI (n=12,220) NSTEACS (n=4,772) 
pPCI (late) 
pPCI (time missing) 
None† 
0.941 (0.773, 1.145), 0.542 
0.690 (0.532, 0.893), 0.005 
0.836 (0.675, 1.035), 0.100 
0.610 (0.463, 0.802), <0.001 
0.967 (0.479, 1.952), 0.926 
1.496 (0.593, 3.773), 0.393 
Random Effects estimate (R squared, Akaike 
Information Criterion) 
0.215‡ (0.361‡, 14134‡) 0.118‡ (0.354‡, 9471‡) 0.378‡ (0.365‡, 4133‡) 
* Values describe odds ratio (95% confidence interval), p value unless stated; ** Per whole unit increase; *** Estimates on the logarithmic scale; † Reference 
category (Medical History variables compared with absence of condition); ‡Median from 25 datasets 
CABG- Coronary Artery Bypass Graft; CCU- Cardiac Care Unit; COPD- Chronic Obstructive Pulmonary Disease; ECG- Electrocardiogram; ED- Emergency 
Department; EMS- Emergency Medical Service; LBBB- Left Bundle Branch Block; MI- Myocardial Infraction; OHCA- Out-of-Hospital Cardiac Arrest; (p)PCI- 
(primary) Percutaneous Coronary Intervention; PEA- Pulseless Electrical Activity; VF- Ventricular Fibrillation; VT- Ventricular Tachycardia 
  
 
